Global governance of antimicrobial resistance
Lancet
.
2018 May 19;391(10134):1976-1978.
doi: 10.1016/S0140-6736(18)31117-6.
Epub 2018 May 17.
Authors
Connor Rochford
1
,
Devi Sridhar
2
,
Ngaire Woods
1
,
Zia Saleh
1
,
Lars Hartenstein
3
,
Hemant Ahlawat
3
,
Ed Whiting
4
,
Mark Dybul
5
,
Otto Cars
6
,
Eric Goosby
7
,
Andrew Cassels
8
,
German Velasquez
9
,
Steven Hoffman
10
,
Enis Baris
11
,
Jonathan Wadsworth
11
,
Martha Gyansa-Lutterodt
12
,
Sally Davies
13
Affiliations
1
Blavatnik School of Government, University of Oxford, Oxford, UK.
2
Global Health Governance Programme, The University of Edinburgh, Edinburgh, UK.
3
McKinsey and Company, Social Sector Hub, Geneva, Switzerland.
4
Wellcome Trust, London, UK.
5
Center for Global Health and Quality, Georgetown University, Washington, DC, USA.
6
Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
7
Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA.
8
Global Health Centre, The Graduate Institute, Geneva, Switzerland.
9
Special Adviser for Health and Development, South Centre, Geneva, Switzerland.
10
Global Strategy Lab, York University, York, UK.
11
World Bank Group, Washington, DC, USA.
12
Ministry of Health, Accra, Ghana.
13
Department of Health and Social Care, London SW1H OEU, UK. Electronic address: sally.davies@dh.gsi.gov.uk.
PMID:
29864011
DOI:
10.1016/S0140-6736(18)31117-6
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Drug Resistance, Bacterial*
Global Health / legislation & jurisprudence*
Health Policy
Humans
International Cooperation
Grants and funding
Wellcome Trust/United Kingdom